Search

everythinglearnresearchcommunity

for

Search:↓

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Women with acne have lower levels of a specific hormone marker than women without acne.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

The hair coat disorder in Schipperkes is similar to Alopecia X and involves increased androstenedione levels and hair cycle arrest.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Finasteride safely lowers DHT levels without affecting testosterone.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.